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ABSTRACT 
 
Characterisation of particulates in therapeutic monoclonal antibody (mAb) formulations is 
routinely extended to the sub-visible size-range (0.1-10 Pm). Additionally, with the increased 
use of pre-filled syringes (PFS), particle differentiation is required between proteinaceous and 
non-proteinaceous particles such as silicone-oil droplets. Here, three orthogonal techniques: 
Raster Image Correlation Spectroscopy (RICS), Resonance Mass Measurements (RMM) and 
Micro-Flow Imaging (MFI), were evaluated with respect to their sub-visible particle 
measurement and characterisation capabilities. Particle formation in mAb PFS solutions was 
evaluated with increasing polysorbate-20 (PS-20) concentrations. All three techniques 
provided complementary but distinct information on protein aggregate and silicone-oil 
droplet presence. PS-20 limited the generation of mAb aggregates during agitation, while 
increasing the number of silicone-oil droplets (PS-20 concentration dependant). MFI and 
RMM revealed PS-20 lead to the formation of larger micron-sized droplets, with RICS 
revealing an increase in smaller sub-micron droplets. Subtle differences in data sets 
complicate the apparent correlation between silicone-oil sloughing and mAb aggregates¶ 
generation. RICS (though the use of a specific dye) demonstrates an improved selectivity for 
mAb aggregates, a broader measurement size-range and smaller sample volume requirement. 
Thus, RICS is proposed to add value to the currently available particle measurement 
techniques and enable informed decisions during mAb formulation development. 
 
Key words: particle, monoclonal antibody, protein aggregation, silicone-oil, primary packaging, 
raster image correlation spectroscopy,  
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1. Introduction 
There is an estimated production of 3.5 billion pre-filled syringe (PFS) units per year for therapeutic 
biopharmaceutical drug (e.g. monoclonal antibody (mAb)) administration, with a potential to grow to 
6.7 billion units by 2020 (TMR, 2013),(Rapra, 2015). The increase in PFS use is driven by factors 
such as the ease of use, advantages in safety, reductions in drug overfill and patient self-
administration; all of which reduce the incidence of hospitalisation and associated costs (Condino, 
2005).  
One of the challenges for the formulation scientist is to ensure the stability of the formulated mAb 
throughout the products lifetime, in the preferred presentation. Protein aggregation has been found to 
arise during and after fill-finish steps; which may develop from mechanical and/or agitation stress or 
from interaction with primary packaging components (Baldwin, 1988). Silicone-oil is a widely-
utilised lubricant in PFS, facilitating ease of plunger movement in syringes and injection with 
hypodermic needles (Thirumangalathu et al., 2009); however, exposure to sloughed silicone-oil 
droplets has been suggested to adversely impact formulation stability (Gerhardt et al., 2014; Shi and 
Ladizhansky, 2012). Initial indication of adverse effects from silicone-oil  was found in the 1980s 
following correlation of insulin particle formation with elevated blood glucose levels, in diabetics 
administered with the product (Baldwin, 1988). Later studies on agitation stress have shown the loss 
of soluble protein in PFS to be a particular problem during transportation (Gerhardt et al., 2014).  
Furthermore, agitation at higher speeds was correlated with an increase in monomer loss in reported 
shaking studies (Thirumangalathu et al., 2009). Subsequently, a number of silicone-oil related 
mechanisms underlying particulate formation have been proposed, exemplified by dispersed droplets 
acting as nucleation sites for protein aggregation (Majumdar et al., 2011); adsorption-destabilization 
of protein onto the silicone-oil/water interface (Thirumangalathu et al., 2009); and silicone-oil droplet 
surface charge neutralisation by adsorbed proteins resulting in agglomeration (Basu et al., 2013; 
Ludwig et al., 2010). 
The size range of protein and silicone-oil particulates is generally wide (Table 1 presents the various 
size ranges and common terminologies used) (Ludwig et al., 2011; Philo, 2006; Philo, 2009; 
Weinbuch et al., 2013b). The United States Pharmacopeia (USP) FKDSWHU µ3DUWLFXODWH 0DWWHU LQ
,QMHFWLRQV¶!defines concentration limits for particles in parental solutions WKDWDUH 10 and 25 
Pm (Pharmacopeia, 2012b). 863 FKDSWHU µ6XEYLVLEOH 3DUWLFXODWH 0DWWHU LQ 7KHUDSHXWLF 3URWHLQ
,QMHFWLRQV¶!PDNHVWKHUHFRPPHQGDWLRQWRPRQLWRUSDUWLFOHVPZLWh a supporting chapter 
<1787> giving guidance on the expanded techniques that can be used and size ranges (Pharmacopeia, 
2012a).  Based on the USP recommendations, the commercially available Micro-Flow Imaging (MFI) 
system, detecting particles from approximately 1 Pm to 400 Pm (Zolls et al., 2012),(Sharma et al., 
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2010b), is commonly used in the industry to assess sub-visible particulates alongside more established 
USP methods such as light obscuration (Pharmacopeia, 2012a, b). The potential immunogenic risk of 
smaller sub-visible aggregates (0.1-10 Pm) has been discussed by Carpenter et al (Carpenter et al., 
2009) and Singh et al (Singh, 2013; Singh et al., 2010) and regulatory submissions therefore may 
include quantitative characterisation of micron-sized aggregates (1- ȝP DQG TXDlitative 
characterisation of sub-micron aggregates (0.1- ȝP LQ the early stages of development 
(Pharmacopeia, 2011; Weinbuch et al., 2013b). With the current particle detection technologies, an 
µanalytical gap¶ around 1 Pm still remains; consequently there is a drive for the development of new 
particle metrology tools (Gross et al., 2016). Furthermore, there is a high interest in developing 
technologies which are also capable of particle differentiation i.e. between protein and foreign matter, 
such as silicone-oil. In response to this predicament, in the last decade several new analytical 
technologies have been introduced in order to detect and characterise aggregates; offering the 
capability to extend the detectable size range of particles from 30 nm to 10 Pm, through combining 
orthogonal technologies (Anacelia Ríos Quiroz 2015). For example, the recently developed 
Resonance Mass Measurement (RMM) system (Archimedes) has been utilised alongside MFI, as a 
particle metrology tool WREULGJHWKHDQDO\WLFDOVL]HµJDS¶IRUSDUWLFXODWHVin the 0.5-5 µm size range, 
and similar to MFI, discriminate between silicone-oil droplets and protein aggregates. However, the 
focus of the study was on large sub-micron and micron-sized particles through the utilisation of the 
RMM µmicro sensor¶, with a lower detection limit of 0.5 Pm (Pharmacopeia, 2011; Weinbuch et al., 
2013b).  
 
Table 1: Common terminology used for various protein aggregate size ranges (Carpenter et al., 2009; Narhi et 
al., 2012; Ríos Quiroz et al., 2015; Zolls et al., 2012). 
Common terms  Size in Diameter 
Nano-metre aggregate, oligomer  < 100 nm 
Sub-micron aggregates 0.1-1 Pm 
Smaller sub-visible aggregates 0.1-10 Pm 
Sub-visible particles, micron aggregates 1-100 Pm 
Visible particles >100 Pm 
Analytical size gap 0.5-5 µm 
 
Raster Image Correlation spectroscopy (RICS) is an image analysis tool, originally developed by 
Digman et al (Digman et al., 2005).  We recently reported a comparison of particle size distributions 
in the gap region with the novel application of RICS, by extrinsic aggregate labelling, against 
Dynamic Light Scattering (DLS) and MFI, in simple mAb formulations (e.g. in the absence of 
silicone-oil and surfactant). RICS was demonstrated to measure a broad particle size range (i.e. 10 nm 
- ~100 Pm) for stressed mAb samples (i.e. thermal and freeze-thaw stress) (Hamrang et al., 2015); 
thereby providing scope for the application of RICS in more complex formulations. 
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This manuscript reports the quantitative evaluation of protein and silicone-oil particulates formed in 
PFS solutions, both within and outside the analytical size gap range. We compare the complementary 
of RICS, detecting particles from 30 nm-10 Pm, against RMM and MFI which are capable of particle 
sizing over the sub-micron (~ 0.1- ~ 5 µm, through the use of the nano and micro sensor) and micron 
(> 1 µm) sizes ranges, respectively. The PFS solutions, in the presence and absence of polysorbate-20 
(PS-20), were subjected to agitation stress via end-over-end rotation, used to model stress during 
transportation (Gerhardt et al., 2014; V, 2011). There are numerous studies assessing the mechanisms 
of mAb aggregation (Li et al., 2011; Morris et al., 2009) and the effects of  silicone-oil (Basu et al., 
2013; Gerhardt et al., 2014; Jones et al., 2005; Weinbuch et al., 2013b) or polysorbate surfactants 
(Agarkhed et al., 2013; Khan et al., 2015) in influencing the aggregation process; such studies include 
novel methods to reduce in situ mAb aggregation in PFS (Depaz et al., 2014). However, the focus has 
been the larger sub-visible size range of particulates i.e. > 0.5 Pm (Felsovalyi et al.; Krayukhina et al., 
2015; Teska et al.); due to the current lack of available technologies that are sensitive to the detection 
of smaller particles, whilst capable of differentiating between proteinaceous and foreign particulates 
(e.g. silicone-oil). Herein, the ability of RICS to characterise aggregates in solutions containing 
silicone-oil droplets via extrinsic fluorescent dyes is also evaluated: the selectivity of RICS (through 
the use of a specific dye) is compared with the efficiency of RMM and MFI (based on particle 
buoyancy and optical parameters for RMM and MFI, respectively) in particle differentiation. The 
assessment of size and concentration of particulates generated in siliconized PFS containing 
formulated mAb is reported utilising all three techniques.  
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2. Materials and Methods 
2.1 Materials 
A bi-VSHFLILF PRQRFORQDO DQWLERG\ KHUHLQ WHUPHG µ&2(-¶ ZDV NLQGO\ SURYLGHG E\ 0HGLPPXQH
(Cambridge, UK). 1 mL, long, sterile, ready to fill BD HypakTM glass siliconized syringes were 
purchased from Becton Dickinson and Company (New Jersey, US).  
All buffer components including sucrose, L-histidine and PS-20 were of analytical grade or higher, 
purchased from Sigma Aldrich (Dorset, UK) and used without further purification.  
SYPRO® Red and SYPRO® Orange dyes were obtained from Thermo Scientific (Leicestershire, 
UK) at a concentration of 5000× (in DMSO). All buffers and solutions were prepared with Millipore 
de-LRQLVHGZDWHU0ȍFPDQGSUH-filtered prior to stress experiments. 
2.2 Methods 
2.2.1 Sample Preparation  
All solutions were prepared in a pH 6 buffer composed of 25 mM histidine and 235 mM sucrose. 
COE-08 solutions were prepared at a final concentration of 10 mg/mL in the presence of 0, 0.02 and 
0.05% w/v PS-20 and placed in syringes. Control syringes were filled with buffer containing the same 
PS-20 concentrations i.e. in the absence of mAb. Solutions were placed in the syringes ensuring a 
consistently sized air bubble, of a height of approximately 1mm. Multiple syringes were used per 
condition to ensure sufficient sample volume for all three instruments. Syringes were placed on an 
end-over-end rotator at ambient temperature (21qC) in a thermostatically-controlled environment for a 
24 hour agitation period at 20 rpm. In parallel, non-agitated samples (of the same described solutions) 
were stored in an open rack on the benchtop. 
2.2.2 Analysis of Particulates with Confocal Microscopy (RICS)  
SYPRO® Red and SYPRO® Orange (Thermo Scientific, Leicestershire, UK), used to label protein 
aggregates and silicone-oil droplets, respectively, were added to samples (post-experiment) 15 
minutes prior to visualisation with confocal microscopy at a final working concentration of 2.5×. 
A Zeiss 510 Confocor 2 (Zeiss, Jena, Germany) confocal microscope equipped with a c-Apochromat 
40×/1.2NA water-immersion objective was utilised for image acquisition. For SYPRO® Red 
solutions, imaging was carried out by exciting the dye with a Helium-Neon laser at 543 nm and the 
emitted fluorescence collected above 585 nm (LP585 filter set). Excitation of SYPRO Orange® was 
carried out at 488 nm (Argon laser) and the emitted fluorescence collected with a 560-615 nm 
bandpass filter. Confocal image time series of 1,024 × 1,024 pixel resolution were captured over 100 
frames with a corresponding pixel dwell time of 6.4 microseconds. In-house RICS software (ManICS) 
was applied to analysis of images acquired using confocal microscopy. A full description of the RICS 
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algorithm has been described elsewhere (Digman et al., 2005; Hamrang et al., 2012). The 
aforementioned image time series were sub-divided into 32x32 pixels region of interest (ROI) and the 
diffusion coefficients (D) within each ROI was generated (Figure 1a). All fits possessing a R2 below 
0.7 were discarded from the fit data prior to generation of particle size distributions. 
RICS-derived diffusion coefficients were subsequently converted to particle diameter using the Stoke-
Einstein equation (following determination of solvent viscosity): 
 ܦ ൌ ݇ܶ ͵ߨߟܽൗ                                                                                                             Equation 1 
 
Where D refers to the diffusion coefficient, k refers to the Boltzmann constant, T the temperature at 
which the measurements were performed, Ș solvent viscosity and a the hydrodynamic diameter.  
2.2.3 Resonant Mass Measurement (RMM) 
Particle size analysis using RMM is based on frequency shifts that are proportional to particle buoyant 
mass, and depend on the sensitivity of a resonator (Weinbuch et al., 2013a). An Archimedes system 
(Malvern, UK) was utilised for RMM of positively- (silicone-oil droplets) and negatively- buoyant 
(protein aggregates) particles. Both the nano and micro sensor were utilised for all solutions. The limit 
of detection (LOD) was set at 0.01 Hz (corresponding to 0.07 µm for protein particles and 0.17 Pm 
for silicone-oil particles) and 0.03 Hz (corresponding to 0.33 µm for protein particles and 0.68 Pm for 
silicone-oil particles) for the nano and micro sensors, respectively. System set-up and cleaning 
procedures are described by the manufacturer and elsewhere (Depaz et al., 2014; Weinbuch et al., 
2013b). 
2.2.4 Micro-flow Imaging (MFI) Analysis  
MFI analysis was performed using a Protein Simple MFI 5000 series (Protein Simple, California, 
USA). Millipore filtered pure water and particle-free buffer (5 mL) was purged through the system to 
remove residual particles prior to measurements and reduce the baseline prior to data acquisition for 
each sample. Subsequently, the sample was introduced at a flow rate of 0.5 mL/min, the illumination 
optimized and 0.5 mL of sample analysed at a corresponding flow rate of 0.1 mL/min. Bright-field 
images, morphometric (i.e. equivalent circle diameter (ECD) and aspect ratio) and particle data 
obtained from the analysis of agitated and non-agitated samples were subjected to analysis of particle 
counts, morphology and size distribution.  
A customised filter was adapted from previous studies (Strehl et al., 2012; Weinbuch et al., 2013a) 
and applied to differentiate between silicone-oil and proteinaceous particles using Origin 2016 
(OriginLab Corporation, Northampton, MA, USA). MFI data obtained from solutions containing 
silicone-oil only or COE-08 aggregates only were utilised to create a customised discriminant analysis 
filter based on four MFI parameters: aspect ratio, intensity mean, intensity minimum and intensity 
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standard deviation (cf. Sharma et al. (Sharma et al., 2010c)). Discriminant analysis uses known 
sample to build a model that can aid data stratification through establishing particle identity (i.e. COE-
08 or silicone-oil). The analysis was applied to each MFI-generated dataset. To set the mAb standard 
during development of the customised filter, an aliquot of COE-08 in buffer was subjected to agitation 
via end-over-end rotation (for 24 hours) in de-siliconized syringes. 
2.2.5 Statistical Analysis  
Unless otherwise stated, a non-parametric one-way ANOVA was performed to assess the influence of 
stress type on resultant size distribution/particle counts. A calculated probability (i.e. p-value) equal or 
less than 0.05 was considered to be statistically significant. 
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3. Results 
The formation of protein aggregates and silicone-oil droplets in PFS, in the presence and absence of 
agitation stress, was evaluated as a function of PS-20 concentration (0, 0.02 and 0.05% w/v). MFI, 
RMM and RICS were utilized, as described in the methods, to selectively evaluate protein aggregate 
formation and silicone-oil sloughing, over the broadest size range. For each technique, the particle 
counts were separated, where applicable, into size ranges of (i) < 0.07 Pm (RICS only), (ii) 0.07-0.5 
Pm (RICS and RMM), (iii) 0.5-5 Pm (RICS, RMM and MFI; with MFI only detecting particles > 1 
Pm), and (iv) > 5 Pm (RICS, RMM and MFI). The size ranges were chosen with respect to the RMM 
nano sensor analytical range of 0.07-0.5 Pm. 
3.1 Fluorescent dye selection for proteinaceous aggregates and silicone-oil droplets for 
RICS analysis 
Since confocal microscopy and RICS analysis rely on fluorophores, RICS may distinguish between 
particles originating from different materials (in this case, protein vs silicone-oil) provided a dye with 
relevant physicochemical properties is selected. SYPRO® Red was previously used to label protein 
aggregates in simple formulations (Hamrang et al., 2015). In this study, SYPRO® Red was used to 
label protein aggregates in more complex formulations (i.e. in the presence of silicone-oil and / or 
surfactant micelles).  
Micrographs (Figure 1b) suggested no apparent labelling of silicone-oil and / or PS-20 micelles by 
SYPRO® Red that would interfere with the data obtained from labelled protein aggregates. Moreover, 
following RICS analysis, the images acquired of buffer-only PFS solutions (i.e. in absence of mAb), 
did not generate any conclusive data as an insufficient correlation (with R2 < 0.7) was obtained. This 
result indicated the significantly higher affinity of SYPRO® Red for proteinaceous aggregates 
compared to silicone-oil droplets and/or PS-20 micelles. 
A second dye was required for labelling silicone-oil droplets. As an initial search did not reveal a 
fluorophore capable of selectively labelling silicone-oil droplets (but not proteinaceous aggregates), 
SYPRO® Orange was assessed in labelling silicone-oil droplets in buffer-only PFS solutions i.e. in 
the absence of mAb (COE-08) (Nashine et al., 2013; Vedadi et al., 2010). Micrographs (Figure 1b) 
illustrated labelling of silicone-oil droplets by SYPRO® Orange. Following RICS analysis of the 
acquired buffer-only PFS solution images (with SYPRO® Orange), sufficient correlations (with R2 > 
0.7) were obtained. Thus, RICS analysis (with SYPRO® Orange) of silicone-oil droplets was 
assessed in non-mAb solutions only. 
To clarify, for RICS analysis, SYPRO® Red was utilised to label protein aggregates in mAb PFS 
solutions, and SYPRO® Orange for labelling silicone-oil droplets in mAb-free PFS solutions. 
 
Figure 1 
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3.2 Assessment of mAb Aggregation in Siliconized PFS 
Protein particle counts (particle counts per mL) by each technique (RICS, RMM and MFI) are 
presented in Figure 2. A broad range of COE-08 aggregate sizes is illustrated in the non-agitated 
(Figure 2, left) and agitated (Figure 2, right) PFS solutions consistent with our previous work 
(Hamrang et al., 2015). The size distributions of the protein particles, clearly showing the outliers, can 
be seen in the SI (Figure S1).  
When assessing the particle profiles of the three techniques (Figure 2), complementary is observed in 
relation to (i) higher aggregate counts in the absence of PS-20 following agitation and (ii) the greater 
presence of smaller particles: significantly higher (p < 0.05) absolute aggregate counts were measured 
in agitated PFS solutions in the absence of PS-20, by all three techniques. An overall assessment of 
the separated particle size ranges indicates that the larger the particle size, the smaller the observed 
particle count will be (a typical trend already found in aggregate solutions) (Ripple and Narhi, 2015; 
Singh et al., 2010). In relation to this assessment, the two main observations were, (i) significantly 
lower absolute particle concentrations (particles per mL) detected by MFI in comparison to RMM, for 
all PFS solutions (approximately three orders of magnitude) and (ii) the higher absolute aggregate 
counts in the 0% w/v PS-20 agitated samples were due to the significantly higher particle counts (p < 
0.05) in the 0.5±5 Pm size range by MFI and significantly higher particle counts (p < 0.01) in the 
0.07±0.5 Pm size range by RMM and RICS.  
Additionally, when assessing the particle size ranges across the three techniques, a pattern is observed 
ZKHQFRQVLGHULQJHDFK WHFKQLTXH¶VDQDO\WLFDO FDSDELOLW\, the sampled volume, and the trend of low 
incidence of larger particles. MFI utilises the largest sampled volume and detected particles > 5 Pm in 
all PFS solutions. By RICS and RMM, only the 0% w/v PS-20 agitated PFS solutions contained 
particles larger than 5 Pm in diameter. The same sample when analysed by MFI contained the highest 
particle concentration in the > 5 Pm size range. Similarly, by RICS only the agitated solutions 
contained particles in the 0.5-5 Pm size range; and the same samples contained higher particle counts 
by RMM and MFI, in comparison to the non-agitated solutions (Figure 2).  
 
Figure 2 
 
 
  
11 
 
3.3 Characterisation of Dispersed Silicone-oil in PFS 
3.3.1 Silicone-oil Droplets in PFS Containing Buffer Only (no mAb) 
Dispersed silicone-oil droplets in buffer-filled non-agitated and agitated PFS solutions, in the presence 
of 0, 0.02 and 0.05% w/v PS-20, were characterized by RMM, RICS and MFI as described in the 
methods. Silicone-oil droplet counts are presented in Figure 3 and the size distributions can be seen in 
the SI (Figure S2).  
 
It is observed that the presence of PS-20 resulted in significantly higher total droplet counts (p < 
0.05), for non-agitated and agitated PFS solutions (Figure 3). This is an interesting outcome as the PS-
20 solutions had the lowest protein aggregate counts, as seen in Figure 2. The results illustrate that 
PS-20 had a more dominant effect than agitation in the sloughing of silicone-oil in PFS.   
 
Similarly to the mAb profiles, higher concentrations of smaller sized oil droplets are detected by all 
three techniques (Figure 3), for all solutions. The smaller size ranges for RMM (i.e. 0.07-0.5 Pm) and 
RICS (< 0.07 and 0.07-0.5 Pm) detected significantly higher oil droplet counts (p < 0.05) in the 
presence of PS-20 (non-agitated and agitated solutions). Larger silicone-oil droplets i.e. > 5 Pm, 
detected by MFI, were also greater in presence in PS-20 agitated samples.  
 
As with the mAb data in Figure 2, the differences in sampled volumes across the techniques and the 
low incidence of larger particles may explain the results in the overlapping size ranges. For example, 
RMM only measured particles larger than 5Pm in the 0.05% w/v PS-20 PFS solutions (non-agitated 
and agitated). RICS detected silicone-oil particles in the 0.5±5 Pm size range in the presence of PS-20 
(0.02 and 0.05% w/v) or following agitation, and only detected silicone-oil particles larger than 5 Pm 
in the 0.05% w/v PS-20 agitated solutions (Figure 3).  
 
Figure 3 
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3.3.2 RMM and MFI Characterisation of Silicone-oil Droplets in mAb PFS Samples 
Silicone-oil droplet counts in the mAb PFS solutions were determined by RMM and MFI 
(distinguishing between proteinaceous particles and silicone oil droplets as described in the methods) 
and are presented in Figure 4.  The silicone-oil size distributions can be seen in the SI (Figure S3). 
 
Both RMM and MFI showed a greater concentration of larger silicone-oil droplets in the presence of 
PS-20 following agitation (PS-20 concentration dependant): similar to the buffer-filled PFS data 
(Figure 3), the only solutions containing particles larger than 5 Pm by RMM were in the presence of 
PS-20. Following agitation, MFI detected a higher concentration of particles larger than 5 Pm in the 
PS-20 samples. Conversely, unlike RMM, MFI data showed differences in silicone-oil droplet counts 
between the mAb PFS (Figure 4) and buffer-only PFS solutions (Figure 3): significantly higher total 
droplet counts were observed in the 0% w/v PS-20 agitated mAb PFS solutions (Figure 4). Particle 
size separation showed this was due to the significantly higher particle counts in the 0.5-5 Pm size 
range (p < 0.01).  
 
It is important to note that differentiation of protein and silicone-oil particles with MFI proved 
problematic; even with the use of the discriminant analysis described in the methods. This is a 
problem observed in previous papers due to optical similarities between protein and silicone-oil 
particles with a diameter less than 4Pm (Zölls et al., 2013; Zolls et al., 2012). Table 2 presents the 
(apparent) protein concentrations in buffer-only (i.e. mAb-free) PFS solutions determined by MFI, 
following discriminant analysis. The apparent protein concentrations determined for the non-agitated 
and agitated PFS solutions were above the background count limit of the MFI system i.e. the 
threshold for a clean run of water (determined as 200 particles per mL). Thus, particle differentiation 
issues between protein and silicone-oil following discriminant-analysis are indicated. This result is 
exacerbated for particle numbers in the lower size range, i.e. 0.5- 5 Pm; as the concentration for 
particles > 5 Pm is less than the background limit, unlike the 0.5-5 Pm size range. Thus it is possible 
that the (apparent) higher silicone-oil particles per mL in the 0% (w/v) PS-20 (mAb PFS) agitated 
solutions (Figure 4) could be a result of particle differentiation issues between protein and silicone-oil 
in the lower MFI size-range in this study (i.e. 0.5-5 Pm). 
 
Table 2: Apparent protein concentrations in buffer-filled PFS solutions determined by MFI (following 
discriminant analysis). Values represent averages with std. dev. for n=3. 
 
Solution Total (1-10 Pm) 1-5 Pm > 5 Pm 
Buffer in PFS Non-Agitated 1796 ± 393 1711 ± 380 85 ± 27 
Buffer in PFS Agitated  4133 ± 313 4004 ± 370 129 ± 57 
 
Figure 4  
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4. Discussion 
4.1 Considerations Regarding the Different Techniques 
The information gained from the various commercially-available particle metrology technologies has 
recently been subjected to considerable discussion, as highlighted by Ripple and Dimitrova (Ripple 
and Dimitrova, 2012) and Quiroz et al (Ríos Quiroz et al., 2015). Common to all techniques 
extrapolating data obtained from small sample volumes or in dilute samples, is the uncertainty in 
particle-size data approaching the technique detection limit. The substantial differences in sampled 
volumes across the three techniques in the present study: RICS (~2 x 10-9 mL) < RMM (~4 x 10-6 mL 
and ~1 x 10-4 mL by the nano and micro sensors, respectively) < MFI (3 x 10-1 mL), may explain the 
differences observed in the data in the overlapping size ranges between the techniques. Low sampled 
volumes reduce the likelihood of detecting larger particles present in low concentrations (Anacelia 
Ríos Quiroz 2015). On the other hand, a significant sample volume is required to generate statistically 
significant particle counts per dose unit. Consequently, the argument for poor precision of new 
techniques in favour of light obscuration is debatable since all techniques are known to suffer from 
caveats. For example, in the case of HIAC and MFI, both of which are optical-based particle counting 
techniques, the techniques are influenced by the refractive index difference between protein particles 
and the formulation. As highlighted by Ripple and Hu (Ripple and Hu, 2015) and Zölls et al (Zölls et 
al., 2013), the change in refractive index at higher concentrations has led to the underestimation of 
particle concentrations. Hence, although novel and emerging techniques may not be appropriate for 
quality control in their current state, they are capable of monitoring the early stages of aggregation, 
require minimal sample volume and are therefore directly relevant to early stages of formulation 
development. Thus the main focus of the present work was to assess the presence of particulates that 
may not be easily detected by light obscuration or MFI i.e. in the submicron size range and smaller. 
This manuscript compares the particle trends / concentrations across MFI, RMM (micro and nano 
sensor) and RICS. 
MFI has received much attention in the analysis of large protein particles (i.e. >1 Pm) (Sharma et al., 
2010a; Sharma et al., 2010c; Wuchner et al., 2010) as the volume and the size-range matches 
regulations; in regards to their morphology, and recently in differentiating between protein and 
silicone-oil particles using customised filters (Strehl et al., 2012; Weinbuch et al., 2013b). The 
discriminant analysis used in this study is based on certain particle parameters relating to apparent 
optical properties and circularity (aspect ratio, intensity mean, intensity minimum and intensity 
standard deviation), devised by Weinbuch et al (Weinbuch et al., 2013b). However, due to some 
optical similarities between mAb and silicone-oil, the reliability of this analysis has previously been 
questioned for particles < 4Pm (Weinbuch et al., 2013b; Zölls et al., 2013; Zolls et al., 2012). 
Supporting previous literature, this study observed a significant apparent presence of COE-08 
particles above the background count limit in mAb-free PFS solutions (Table 2). The misclassification 
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error with MFI may offer some explanations for the possible effects observed in the 0.5-5 Pm size 
range in this study i.e. accounting for the higher oil droplet concentration in the 0% w/v PS-20 
agitated solutions in Figure 4, which is inconsistent with other data-sets. Thereby, for mixed solutions 
(i.e. protein and silicone-oil), it is recommended to utilise MFI alongside another method possessing 
an overlapping size range (covering 1-5 Pm) and also capable of particle differentiation i.e. RMM 
(Weinbuch et al., 2013b; Zolls et al., 2012).  
Overall, results from the current study are consistent with previous reports showing complementarity 
between RMM and MFI (Weinbuch et al., 2013b) (Figure 2 for protein aggregates, and Figures 3-4 
for silicone-oil droplets). This is true when accounting for the strong dependence between number of 
particles and their sizes (Ríos Quiroz et al., 2015; Ripple and Narhi, 2015), wherin a significantly 
greater aggregate count in the lower sub-visible size range was measured following and prior to 
agitation in PFS. Through the use of the RMM nano sensor and RICS, the smaller-sized aggregate 
population was analysed, detecting particles < 0.5 Pm in diameter. There are limited published reports 
on the use of RMM (Panchal et al., 2014; Weinbuch et al., 2013b; Zölls et al., 2013), and to our 
knowledge, this is the first study reporting the use of both RMM sensors on the same solutions. A 
careful observation of size ranges detected by RMM micro and nano sensors (SI, Figure S1) revealed 
uncertainties regarding the use of both detectors. While the size ranges of the nano and micro sensors 
are intended to overlap, an overlap of particle sizes is not always observed, raising questions about the 
likelihood of detecting poorly-populated larger particles in the small sampled volume. The same 
observation was found in the silicone-oil data acquired by RMM (Figure S3).  
It is noteworthy that RMM exploits the differences in density to distinguish between particles but 
requires the use of both the nano and micro sensors to cover a broad size range, which increases 
measurement time and sample consumption. Furthermore, RMM has particle concentration limits, 
accruing errors for samples with low particle counts (Weinbuch et al., 2013b), but also for samples 
with particle counts > 2×106 particles/mL where there is a risk of high coincidence and dilution is 
required (Amin et al., 2014; Panchal et al., 2014). Concentration limits appear to be a downfall for 
many technologies characterising in the lower size range. For example, Nano-Particle Tracking 
Analysis (NTA), which also has the ability of particle differentiation through using fluorescence, has 
similar concentration limits to RMM. The combined effect of adsorption (from contact with glass and 
stainless steel during measurement) and sheer (during injection) has also been reported to create 
aggregates (Filipe et al., 2010; Funke et al., 2016).  
With regard to RICS, the main challenge was the selection of an appropriate dye. In this study, the 
selectivity of SYPRO® Red for protein aggregates was demonstrated, with SYPRO® Orange 
labelling both protein aggregates (Goldberg et al., 2011; He et al., 2010; Nashine et al., 2013) and 
silicone-oil droplets (Figure 1). When using RICS, fluorescent dye selection should be considered on 
a case-by-case basis. However, following the selection of the fluorophore, no change of detector was 
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required and the trends for particle size and concentration observed with RMM were consistent with 
those observed by RICS.  
It should be mentioned that comparison of particle concentrations from MFI, RMM or RICS data 
needs consideration due to fundamental differences in measurement between these techniques. MFI 
and RMM both use flow that can potentially bias the movement of particulates such that particles are 
counted within a certain sampled volume. With the present settings, RICS detects a number of 
particles in the focal volume of the objective, but particles moving by Brownian motion may cross 
this focal volume more than once. Indeed, Figures 2 and 3 suggest higher particle counts than those 
determined by RMM and MFI. Thus, in the current setting, direct comparison of particle counts 
between RMM, MFI vs RICS cannot be made. It is foreseen that microfluidics may be of use with 
RICS; Rossow et al. have demonstrated the use of RICS in the presence of flow (Rossow et al., 2009). 
 
It is important to consider the uncertainties carried by different technologies, especially when 
comparing the acquired data-sets across multiple techniques. Nevertheless, considering all of the 
above points, the trends across the three techniques i.e. the effect of agitation and the presence of PS-
20 on aggregation formation vs the dispersion of silicone-oil droplets in the PFS solutions, are the 
same.  
4.2 Agitation in Siliconized PFS Increases Aggregation Formation 
All samples containing 0% w/v PS-20 contained a significantly larger aggregate count following 
agitation, which is consistent with the widely known effect that agitation has on protein solutions 
sheared at the air-water interface (Khan et al., 2015; Treuheit et al., 2002). Due to the increased use of 
PFS in fill-finish manufacturing, it is important to understand the impact of siliconized syringes on the 
stability of formulated mAb during storage and transport in the presence or absence of agitation. 
Previous literature indicate that the presence of silicone-oil can result in aggregation increase 
following agitation; the effect being silicone-oil concentration dependant (Jones et al., 2005). Other 
studies have indicated that silicone-oil itself i.e. in the absence of an additional stress such as 
agitation, does not impact aggregation formation (Gerhardt et al., 2014; Thirumangalathu et al., 2009).  
In this study, silicone-oil droplets and aggregated protein were detected in all mAb-filled (COE-08) 
PFS solutions (Figure 2 for aggregates and Figure 4 for silicone-oil). As the PS-20 solutions contained 
the lowest aggregate counts (Figure 2) whilst containing the highest silicone-oil droplet counts 
(Figures 3-4), no correlation between protein aggregation and silicone-oil droplet presence was 
observed. Based on this, and previous literature, it may be that the effect of silicone-oil on mAb 
stability is a case by case basis.  
Considering the surface-active properties of PS-20, the observed increase of silicone-oil droplets 
generated in PS-20 samples (Figure 3) was consistent with previous reports (Felsovalyi et al., 2012). 
This observation needs to be tempered against the imaging method used for RICS which relies on 
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inverted microscopy of a small sample volume within a narrowly-defined plane of focus across which 
droplets move by Brownian motion and by virtue of their density relative to the bulk. Here, we have 
assumed that PS-20 stabilised silicone-oil droplets in solution (Ludwig et al., 2010), and silicone-oil 
droplets in the absence of PS-20 have the same density and are therefore positively buoyant in 
aqueous solution. Nevertheless, silicone-oil extracted from the surface by PS-20 appears to increase 
the number of droplets in the micrometre region µRXWOLHUV¶REVHUYHGLQFigure S2).  
4.3 PS-20 limits the Formation of Aggregates in Siliconized PFS following Agitation 
Agitated PFS solutions in the absence of PS-20 generated the highest protein aggregate counts 
following agitation (Figure 2). More so, the presence of PS-20 reduced the protein particle counts to 
their respective baselines, i.e. the counts in non-agitated solutions for the same PS-20 concentration. 
RICS and RMM showed that PS-20 significantly reduced small sub-visible aggregates, while MFI 
showed that PS-20 limited the development of larger aggregates (Figure 2). A number of studies have 
attempted to explain the protective mechanisms of polysorbates in preventing aggregation (see Khan 
et al (Khan et al., 2015)). The predominant mechanism is assumed to be adsorption competition 
between the surfactant and the protein at the air/liquid (or glass/liquid) interface. As a result, 
adsorption-denaturation of the protein at these interfaces is attenuated (Khan et al., 2015; Lee et al., 
2011; Thirumangalathu et al., 2009). A further suggestion is that surfactant molecules may form 
micelles (at concentrations above the critical micelle concentration) that shield exposed protein 
hydrophobic surfaces, assuming partial or complete denaturation, and attenuate protein-protein 
interactions (Bam et al., 1998; Mahler et al., 2005).  
Protein destabilising effects in increasing polysorbate concentrations have been observed in other 
studies (Agarkhed et al., 2013; Amand Bhaskar, 2014). In this study, no significant differences in 
aggregate formation were observed between the two PS-20 concentrations (Figure 2), although a 
higher concentration of silicone-oil droplets is observed in the 0.05% w/v concentration (Figures 3-4). 
Nevertheless, determining the optimal polysorbate concentration for a specific mAb formulation must 
be accounted for during formulation development.  
5. Conclusions 
All three techniques demonstrated that the presence of PS-20 in mAb solutions contributes to a 
significant reduction in proteinaceous aggregates following agitation, consistent with the surfactant 
activity of PS-20. Comparison of the data sets imply that there is no interplay between the sloughing 
of silicone-oil droplets in PFS and the exacerbation of protein aggregate formation in the sub-visible 
size range. While advanced particle characterisation technologies are available to the formulation 
scientist, it is still the case that this is a challenging area and emerging methods, while welcomed, may 
not have yet achieved the expected capability of bridging the current sizing µJDS¶ for sub-visible 
particles. Nevertheless, our data show that they provide complementary information and support 
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methods such as MFI. This study demonstrates that RICS analysis may expand the scope for sub-
visible particle sizing/characterisation and is an orthogonal technique to RMM. Since confocal 
microscopy is well established, RICS offers the potential for widespread application in laboratories 
where specialist equipment may not be available. 
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Figure 1: a. Schematic diagram of RICS. RICS is based on the use of acquired confocal images 
where particles have been fluorescently labelled. Through the autocorrelation of the images, the 
diffusion time is determined. Depending on the timescale of the process, pixel (micro-seconds), line 
(milliseconds) or frame (seconds) correlation methods can be used. Adapted from (Digman et al., 
2005). b. Confocal micrographs representing labelling by SYPRO® Red (Ex: 543 nm, LP585 nm) 
(top) and SYPRO® Orange (Ex: 488 nm, BP560-615nm) (bottom) to PS-20 and sloughed silicone-oil 
droplets from agitated syringes. Micrographs indicate no labelling to silicone-oil by SYPRO® Red 
and labelling of silicone-oil by SYPRO® Orange.  
 
Figure 2: Protein particle counts in mAb PFS solutions, in the presence and absence of agitation, as a 
function of PS-20 concentration (0%, 0.02% and 0.05% w/v). Horizontal and vertical axis represents 
particle counts (particle counts per mL) determined by RICS, RMM and MFI for size ranges (i) < 
0.07Pm, (ii) 0.07-0.5Pm, (iii) 0.5-5Pm and (iv) >5Pm. Axis scale varies per technique to ease 
visualisation of data. Values represent average counts and error bars represent the std. dev. for n=3. 
 
Figure 3: Silicone-oil droplet counts in buffer-filled PFS solutions, in the presence and absence of 
agitation, as a function of PS-20 concentration (0%, 0.02% and 0.05% w/v). Horizontal and vertical 
axis represents particle counts (particle counts per mL) determined by RICS, RMM and MFI for size 
ranges (i) < 0.07Pm, (ii) 0.07-0.5Pm, (iii) 0.5-5Pm and (iv) >5Pm. Axis scale varies per technique to 
ease visualisation of data. Values represent average counts and error bars represent the std. dev. for 
n=3. 
 
Figure 4: Silicone-oil droplet counts in mAb PFS solutions, in the presence and absence of agitation, 
as a function of PS-20 concentration (0%, 0.02% and 0.05% w/v). Horizontal and vertical axis 
represents particle counts (particle counts per mL) determined by RMM and MFI for size ranges (i) < 
0.07Pm, (ii) 0.07-0.5Pm, (iii) 0.5-5Pm and (iv) >5Pm. Axis scale varies per technique to ease 
visualisation of data. Values represent average counts and error bars represent the std. dev. for n=3. 
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